Fig. 6
From: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
PRL3 is frequently overexpressed in multiple human cancers. a–k Representative full western blot (WB) of PRL3 protein levels in tumor (“T”) tissues and, where available, patient-matched normal (“n”) tissues from a liver, b lung, c colon, d breast, e stomach, f thyroid, g pancreas, h kidney, i acute myeloid leukemia (bone marrow aspirates), j bladder, and k prostate tissues. Relative molecular masses (in kDa) are indicated on the right of each immunoblot. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as a loading control. Source data are provided as a Source Data file
